Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

AEROVIRONMENT INC (AVAV)

  • Business News
  • June 04, 2026, 11:12 UTC
  • 5
  • 1 comments

INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that AeroVironment, Inc. (AVAV) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Market reaction Comment Full text

TELEDYNE TECHNOLOGIES INC (TDY)

  • Business News
  • June 04, 2026, 11:05 UTC
  • 5
  • 1 comments

Teledyne FLIR Defense Awarded $11.2 Million U.S. Army Contract for Advanced CBRN Sensor Drone Kits

Market reaction Comment Full text

Insmed Inc (INSM)

  • Business News
  • June 04, 2026, 11:02 UTC
  • 7
  • 1 comments

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Market reaction Comment Full text

Ovid Therapeutics Inc (OVID)

  • Business News
  • June 04, 2026, 11:01 UTC
  • 7
  • 1 comments

Ovid Therapeutics Inc. - Ovid Therapeutics to Participate in Upcoming Investor Conferences

Market reaction Comment Full text

GLOBAL-E ONLINE LTD. (GLBE)

  • Business News
  • June 04, 2026, 11:01 UTC
  • 7
  • 1 comments

Global-e Announces Board Authorization of $500 Million Share Repurchase Program

Market reaction Comment Full text

Insulet Corporation (PODD)

  • Business News
  • June 04, 2026, 11:00 UTC
  • 8
  • 1 comments

Insulet - Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions

Market reaction Comment Full text

Bruker Corporation (BRKR)

  • Business News
  • June 04, 2026, 11:00 UTC
  • 7
  • 1 comments

Bruker - Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026

Market reaction Comment Full text

BEYONDSPRING INC. (BYSI)

  • Business News
  • June 04, 2026, 11:00 UTC
  • 4
  • 1 comments

BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value

Market reaction Comment Full text

OCULAR THERAPEUTIX, INC (OCUL)

  • Business News
  • June 04, 2026, 11:00 UTC
  • 4
  • 1 comments

Ocular Therapeutix™ to Participate in Clinical Trials at the Summit 2026

Market reaction Comment Full text

D-WAVE QUANTUM INC. COMMON SHARES (QBTS)

  • Business News
  • June 04, 2026, 11:00 UTC
  • 5
  • 1 comments

D-Wave Certified as a Great Place To Work® Company

Market reaction Comment Full text
  • Previous
  • 2021
  • 2022
  • 2023
  • 2024
  • 2025
  • Next

Search

News categories

  • Technical Exchange News(13871)
  • Event(6229)
  • SEC News(362903)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(199385)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin